Bone conduction headphones allow you to keep your ears open and aware of your surroundings while you listen to music that's loud and clear. That's why they work perfectly as workout headphones ...
If you buy something, we may earn an affiliate commission. A close relative of stock (some might say indistinguishable), bone broth is often used as a base for soups and stews—but it can also be ...
4 The real cause of this disease is still obscure, though the inhibition of the ossification center that would normally form the lateral and inferior borders of the piriform aperture during the fifth ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Treatment may depend on the cause. A sinus infection, also known as sinusitis or rhinosinusitis, occurs when your nasal cavities become swollen and inflamed. Fluid buildup in the sinuses can allow ...
A pimple-like bump or sore inside the nose can sometimes be due to nasal vestibulitis or nasal folliculitis. It is a bacterial infection that can develop when hair follicles become infected ...
But hidden at your pharmacy among the potpourri of cough drops and cold remedies, you can find a low-risk treatment that actually may help: nasal irrigation devices. Several small studies suggest ...
Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
therefore, in this respect, to differ more from the nose-case of the ape, than it does owing to any great development of the nasal bones.
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...